Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MiMedx Group, Inc.(MDXG) | 28,195,249 | 28,195,249 | 0 | $195.39M | $166.63M | 47.56% | -$28.76M |
| Bioventus Inc.CL A(BVS) | 13,021,324 | 13,021,324 | 0 | $74.87M | $155.60M | 44.41% | +$80.73M |
| EyePoint, Inc.(EYPT) | 1,551,521 | 1,551,521 | 0 | $13.50M | $12.40M | 3.54% | -$1.10M |
| TELA Bio, Inc.(TELA) | 4,110,709 | 4,110,709 | 0 | $19.32M | $10.40M | 2.97% | -$8.92M |
| Revance Therapeutics Inc | 457,085 | 457,085 | 0 | $1.17M | $2.37M | 0.68% | +$1.20M |
| MediciNova, Inc.(MNOV) | 1,105,941 | 1,105,941 | 0 | $1.59M | $2.32M | 0.66% | +$729.9K |
| Venus Concept, Inc. | 1,089,190 | 1,089,190 | 0 | $852.8K | $664.8K | 0.19% | -$188.0K |